AAF
RVMD icon

Andra AP-fonden’s Revolution Medicines RVMD Stock Holding History

Andra AP-fonden’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Buy
+16,600
New +$1.68M 0.02% 343

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Andra AP-fonden's RVMD Position: Q1 2026 in Review

Andra AP-fonden opened a new position in Revolution Medicines (RVMD) in Q1 2026: 16,600 shares worth $1.61M. The stake represents 0.02% of the portfolio and ranks #343 among its holdings.

514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Andra AP-fonden held 16,600 shares of Revolution Medicines worth $1.61M as of Q1 2026.
  • Revolution Medicines was a new Andra AP-fonden position in Q1 2026.
  • Revolution Medicines made up 0.02% of Andra AP-fonden's portfolio in Q1 2026, its #343 holding.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.